Search
Seratrodast is used in the treatment of asthma. Seratrodast is an orally potent non-prostaglandin thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor blocker that inhibits allergic asthma caused by PGH2 analogues, leukotriene D4 (LTD4), and platelet-activating factor (PAF). Setrolaster can inhibit not only the immediate tracheal reaction, but also the delayed tracheal reaction and tracheal hyperreactivity.
| Items | Specifications | Results |
| Appearance | Yellow to luminous powder | Yellow powder |
| Loss on drying | ≤1.0% | 0.21% |
| Residue on ignition | ≤1.0% | 0.01% |
| Heavy metals | ≤20ppm | Conforms |
| Residual solvents | Ethanol≤ 5000ppm | 810ppm |
| Assay | ≥99.0% | 99.7% |
| Product parameters | |
| Cas number: | 112665-43-7 |
| Appearance: | Yellow to luminous powder |
| Purity: | 99%min |
| Package details: | 100g/bottle; 1kg/foil bag |
| Brand: | Fortunachem |

Used as an asthma agent.

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية